Amgen Technology definition

Amgen Technology means the Amgen Patents and the Amgen Know-How.
Amgen Technology means all Amgen Patent Rights and Amgen Know-How.
Amgen Technology means the Amgen Know-How, Amgen Inventions and the Amgen Patents.

Examples of Amgen Technology in a sentence

  • Subject to the licenses granted in Section 9.2(a) below, as between the Parties, Amgen shall own all right, title and interest in and to Amgen Technology, and any Confidential Information contained therein shall be considered the Confidential Information of Amgen.

  • For the avoidance of doubt, Amgen shall further retain all rights in Amgen Technology and the Amgen Material and Manufacturing Information not expressly licensed hereunder, including the right to make, have made, use, sell, lease, offer to sell or lease, have sold, import, export or otherwise exploit, transfer physical possession of and transfer title or interest in and to products, other than Licensed Products, for any purpose in the Territory.

  • If the number of persons nominated for election to the Committeeunder clause 25 does not exceed the number of vacancies to be filled, the Chairperson must declare the persons to be duly elected as members of the Committee at the annual general meeting.

  • Delaware Amgen SF, LLC Delaware Amgen Technology (Ireland) Ireland Amgen Technology, Limited Bermuda Amgen USA Inc.

  • Subject to the licenses granted in Section 2.1, as between the Parties, Amgen shall own all right, title and interest in and to Amgen Technology, and any Confidential Information contained therein shall be considered the Confidential Information of Amgen.


More Definitions of Amgen Technology

Amgen Technology means, collectively, [*] Know-How, [*] Know-How, [*] Patent Rights, [*] Patent Rights, and Amgen’s interest in [*] Know-How and Amgen’s interest in [*] Patent Rights.
Amgen Technology means all technology including, but not limited to, trade secrets, know-how, inventions and information (including test data, protocols and screening methodology), and materials (including Compounds), whether patentable or not, directed to products, processes, formulations and/or methods that Amgen discovers, develops, identifies, licenses or acquires independently of Array (i.e., without the use of the Confidential Information of Array). For the avoidance of doubt, it is intended that Amgen Technology shall exclude Array Technology, Collaboration Technology and Joint Technology.
Amgen Technology means, collectively, Amgen Background Patent Rights, Amgen Background Know-How, Amgen Program Patent Rights, Amgen Program Know-How and Amgen's interest in the Joint Patent Rights and Joint Know-How.
Amgen Technology means all INFORMATION relating to the manufacture, use or sale of INTERFERON ALFACON-1 that is licensed to InterMune pursuant to that certain License and Commercialization Agreement dated June 15, 2001, as amended, by and between InterMune and Amgen, including without limitation the Manufacturing Process as defined in the SIDE LETTER AGREEMENT, and all patents and patent applications covering such INFORMATION.
Amgen Technology means, collectively, [*] Know-How, [*] Know-How, [*] Patent Rights, [*] Patent Rights, and Amgen’s ixxxxxst in [*] Know-How and Amgen’s ixxxxxst in [*] Patent Rights.
Amgen Technology means Amgen Patents and Amgen Know-How, subject to Section 5.4.1 or 5.4.3, as applicable, but shall exclude Excluded Technology.
Amgen Technology. 2 1.7 "BLA" 2 1.8 "CMC" 2 1.9 "Combination Product" 2 1.10 "Commercialize" or "Commercialization" 2 1.11 "Commercially Reasonable Efforts" 2 1.12 "Confidential Information" 2 1.13 "Control" 2 1.14 "Default" 2 1.15 "Directly Competitive Product" 2 1.16 "Dollar" 2 1.17 "Drug Approval Application" 2 1.18 "Existing License" 3 1.19 "Existing License Patents" 3 1.20 "Existing Licensor" 3 1.21 "FDA" 3 1.22 "Force Majeure" 3 1.23 "GAAP" 3 1.24 "Infergen" 3 1.25 "IND" 3 1.26 "Interferon alfacon-1" 3 1.27 "Licensed Product" 3 1.28 "Losses" 3 1.29 "Net Sales" 3 1.30 "Ongoing Clinical Trials" 3 1.31 "Other Licensee" 3 1.32 "Patent" 3 1.33 "PEG Know-How" 4 1.34 "PEG Patent" 4 1.35 "PEG Program" 4 1.36 "PEG-Infergen Product" 4 1.37 "Phase III Clinical Trial" 4 1.38 "Phase IV Clinical Trial" 4 1.39 "Planning Period Date" 4 1.40 "Regulatory Approval" 4 1.41 "Regulatory Authority" 4 1.42 "Royalty" or Royalties" 4 1.43 "Sublicensee" 4 1.44 "Supply Terms" 4 1.45 "Term" 4 1.46 "Territory" 4 1.47 "Third Party" 4 1.48 "Trademark" 4 1.49 "Valid Claim" 5